MAP2K7 and urinary bladder carcinoma: Furthermore, heightened expression of NCAPH has been observed in bladder cancer, where it facilitates the proliferation of bladder cancer cells and suppresses their programmed cell death by activating the MEK/ERK pathway, consequently impacting the progression of bladder cancer.